Jin-Wook Chung

Title: Jin-Wook Chung: Innovator in Paclitaxel Composition

Introduction

Jin-Wook Chung is a notable inventor based in South Korea, recognized for his contributions to pharmaceutical formulations. His work primarily focuses on the solubilization of paclitaxel, a critical compound used in cancer treatment. With a commitment to enhancing drug delivery systems, Chung has developed innovative compositions that improve the bioavailability of paclitaxel.

Latest Patents

Chung's most significant patent is titled "Composition For Solubilization Of Paclitaxel And Preparation Method Thereof." This invention relates to a paclitaxel composition designed to solubilize the compound effectively. The composition comprises 4-90% by weight of at least one selected from monoglycerides, 0.01-90% by weight of at least one oil, and 0.01-20% by weight of paclitaxel. Additionally, the invention includes formulations with emulsifiers, enhancing the solubilization process. The resulting composition is an effective delivery system, ensuring high bioavailability and preventing the formation of aggregates when dispersed in water.

Career Highlights

Jin-Wook Chung is currently associated with Daehwa Pharm. Co., Ltd., where he continues to innovate in the field of pharmaceutical sciences. His dedication to research and development has positioned him as a key player in the industry, contributing to advancements in drug formulation.

Collaborations

Chung collaborates with talented individuals such as Hesson Chung and Seo-Young Jeong, who share his vision for improving drug delivery systems. Their combined expertise fosters a collaborative environment that drives innovation in their projects.

Conclusion

Jin-Wook Chung's work in the field of paclitaxel composition exemplifies the importance of innovation in pharmaceutical development. His contributions significantly enhance the effectiveness of cancer treatments, showcasing the impact of dedicated inventors in the medical field.